22:03 24-10-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
17:40 OSCE supports regional explosive ordnance disposal course for specialists from Central Asia, Afghanistan17:23 Kurmanjan Datka to be screened in Los Angeles17:18 Kyrgyz white hat brings Roy Jones Jr. luck in fight vs Hany Atiyo17:14 Electricity social tariff should be made socially-economic to meet growing electricity needs – First Vice PM16:52 China economy to grow 7.4 percent in 2014, 7 percent in 201516:52 Ex-Minister of Tajikistan, 14 others accused of major fraud, Emomali Rahmon's relatives among witnesses16:48 Environmentalists of Kyrgyzstan condemn bill allowing livestock grazing in natural reserves16:38 Kazakh oil output to rise with Kashagan after 2020 - official16:25 Electricity price remained unchanged in Kyrgyzstan for 15 years – First Vice PM16:19 Current water volume in Toktogul dam not enough for electricity generation15:59 Islam Karimov awards Gurbanguly Berdymuhamedov with Independence Order15:53 Asian Para Games: Kazakhstan wins 24 medals ranking 11th15:45 President Atambayev signs order on opening of Embassy of Kyrgyzstan in Baku15:42 Two Afghan districts, bordering with Tajikistan, can move under control of Taliban15:41 Around 3,000 gas cylinders to be handed over to poor families of Osh region15:34 Kyrgyz Energy Ministry promises to keep current electricity tariffs until December 201415:30 Karaganda region to commission 6 new plants by end of 201415:25 Kyrgyzstan exceeds electricity consumption limits for 302 million kWh15:18 Sweden calls off search for submarine15:09 Kyrgyzstan generates 10.1 billion kWh of electricity for 9 months of 2014
Astana
+1° C
Ashgabat
+26° C
Bishkek
+15° C
Dushanbe
+20° C
Tashkent
+20° C
exchange rates
 
71.00
56.08
9.04
1.35
228.98
180.87
29.56
4.35
6.33
4.99
0.78
0.12
3084.28
2367.40
385.74
61.13
3.61
2.85
0.47
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75